Login
Manage Portfolio
Post a StockTalk
Write an Instablog
Get Daily Email Alert
Seeking Alpha
Home
The Macro View
Stocks & Sectors
Global Markets
ETFs
Investing Ideas
Breaking News
Transcripts
Business Intelligence
ViroPharma Inc. (VPHM)
(
)
Quotes
Dashboard
Chart
Historical Prices
Options
Analysis
Articles
Instablogs
StockTalks
Sentiment
Comments
News & PR
Market Currents
Buzz
Twitter: VPHM
Coverage
Top Authors
Cramer
Top Analysts
Business Intelligence
Transcripts
Events
Key Developments
Earnings
History & Projected
Consensus
Peer Earnings
Filings
SEC Filings
Annual Report
Ownership
Major Holders
Insider Trades
Insider Sentiment
Index Membership
Short Interest
Financials
Income Statement
Balance Sheet
Cash Flow
Company
Wikipedia Profile
Officers & Directors
Executive Comp
Comments on VPHM
Biotech Stocks for a Possible Year-End Rally
[View article]
I see you did leave MRNA off your list. MDRNA INC (MRNA) UPDATE NOV.27TH, 2009 AFTER A YEAR FILLED WITH NEW PARTNERS, DRUG APPROVAL, IN...
More »
Comment by
jimmy Turano
Nov 27 08:51 am
|
Rating:
+1
0
Biotech Stocks for a Possible Year-End Rally
[View article]
While I like the Biotech sector, and there are many worthy companies to purchase, with real potential big gains, in my opinion,...
More »
Comment by
jimmy Turano
Nov 23 08:08 am
|
Rating:
+1
0
ViroPharma (VPHM): Q2 EPS of $0.20 beats by $0.02. Revenue of $82M (+25%) vs. $75M. Shares...
[View news story]
beware any "ANALysis" that claims something is "an obvious buy"
Comment by
JW.USC
Nov 9 16:22 pm
|
Rating:
+1
0
Contrarian Stock Screen: Biggest Losers in 2009
[View article]
how can we see this ? print way too small
Comment by
buyforeclosures
Sep 2 11:18 am
|
Rating:
0
0
Cinryze Approved: A Significant Catalyst for Viropharma, Lev Pharmaceuticals
[View article]
Solid growth of Cinryze sales from Viropharma just reported this morning. In terms of looking ahead, DYAX is next up on the plate for...
More »
Comment by
Dan Weiss
Jul 29 13:24 pm
|
Rating:
0
0
ViroPharma (VPHM): Q2 EPS of $0.20 beats by $0.02. Revenue of $82M (+25%) vs. $75M. Shares...
[View news story]
An obvious buy before earnings based on applied technical analysis and recent momentum in biotech sector
Comment by
Beyond Trading
Jul 29 09:19 am
|
Rating:
+4
-2
Contrarian Stock Screen: Biggest Losers in 2009
[View article]
being a CONTRARIAN, defined, says that person KNOWS something from tangible evidence that FUNDAMENTALLY changes the situation, and has...
More »
Comment by
denaliguide
Jul 14 15:47 pm
|
Rating:
0
0
Contrarian Stock Screen: Biggest Losers in 2009
[View article]
We got "engaged" to VDSI a while back and totally believe this company is going to grow like a well fed teenager after all this...
More »
Comment by
fineartconsultant
Jul 12 10:56 am
|
Rating:
0
0
Smaller Pharma Wins the 'Most Valuable' Race
[View article]
Thank you for a very useful stock screen. Several very appealing opportunities in your list. I have a major position in PDLI because I...
More »
Comment by
Alphameister
Jul 1 09:11 am
|
Rating:
0
0
Buying ViroPharma Ahead of June 3rd FDA Decision
[View article]
The PE is pretty high at this point. Used to be a simpler stock to follow. One trick pony though?
Comment by
mlnlaw
Jun 16 21:38 pm
|
Rating:
0
0
ViroPharma: FDA Issues Complete Response Letter for Cinryze
[View article]
VPHM-Temporary setback for a well run company, and creditable team. Good article in seekingalpha May 27th. Potential with teeth in it,...
More »
Comment by
jimmy Turano
Jun 4 17:54 pm
|
Rating:
+1
0
Buying ViroPharma Ahead of June 3rd FDA Decision
[View article]
HOW ABOUT SHAREHOLDERS THINKING THAT A NEW CEO WHO JUST HAD HIS COMPANY 'SIRNA' TAKEN OVER IN A BUYOUT CAN DO THE SAME THING FOR THE...
More »
Comment by
jimmy Turano
Jun 4 17:26 pm
|
Rating:
+1
0
Buying ViroPharma Ahead of June 3rd FDA Decision
[View article]
Did FDA approve Cinryze as planned on June 3rd?
Comment by
Ray Ray
Jun 3 18:24 pm
|
Rating:
0
0
Buying ViroPharma Ahead of June 3rd FDA Decision
[View article]
i like this company other than bio's because it has revenues...a big difference than other speculations....and the bio-availability is...
More »
Comment by
boudreaufarms
Jun 2 21:06 pm
|
Rating:
0
0
Buying ViroPharma Ahead of June 3rd FDA Decision
[View article]
I have been doing this for years. Recently, I haven't had enough time but in the late 90s, I put in $16k and ended up with over $80k in...
More »
Comment by
DGCasey
Jun 1 22:59 pm
|
Rating:
0
0
1
2
3
4
5
6
...
10
Next Page
Biotech Stocks for a Possible Year-End Rally [View article]
Biotech Stocks for a Possible Year-End Rally [View article]
ViroPharma (VPHM): Q2 EPS of $0.20 beats by $0.02. Revenue of $82M (+25%) vs. $75M. Shares... [View news story]
Contrarian Stock Screen: Biggest Losers in 2009 [View article]
Cinryze Approved: A Significant Catalyst for Viropharma, Lev Pharmaceuticals [View article]
ViroPharma (VPHM): Q2 EPS of $0.20 beats by $0.02. Revenue of $82M (+25%) vs. $75M. Shares... [View news story]
Contrarian Stock Screen: Biggest Losers in 2009 [View article]
Contrarian Stock Screen: Biggest Losers in 2009 [View article]
Smaller Pharma Wins the 'Most Valuable' Race [View article]
Buying ViroPharma Ahead of June 3rd FDA Decision [View article]
ViroPharma: FDA Issues Complete Response Letter for Cinryze [View article]
Buying ViroPharma Ahead of June 3rd FDA Decision [View article]
Buying ViroPharma Ahead of June 3rd FDA Decision [View article]
Buying ViroPharma Ahead of June 3rd FDA Decision [View article]
Buying ViroPharma Ahead of June 3rd FDA Decision [View article]